Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12109194 Synergistic combination therapy for treating ALS

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 1, 2022
0
Date of Patent
October 8, 2024
0
Patent Application Number
17684279
0
Patent Citations
‌
US Patent 7432305 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
0
‌
US Patent 7470798 7,8-bicycloalkyl-chroman derivatives
0
‌
US Patent 7514461 Chroman derivatives
0
‌
US Patent 7888334 Mitoquinone derivatives used as mitochondrially targeted antioxidants
0
‌
US Patent 7888335 Mitoquinone derivatives used as mitochondrially targeted antioxidants
0
‌
US Patent 10052299 Alleviating oxidative stress disorders with PUFA derivatives
0
‌
US Patent 10058522 Oxidative retinal diseases
0
‌
US Patent 10058612 Impaired energy processing disorders and mitochondrial deficiency
0
‌
US Patent 10730821 Site-specific isotopic labeling of 1,4-diene systems
0
‌
US Patent 10154983 Neurodegenerative disorders and muscle diseases implicating PUFAs
0
•••
Patent Inventor Names
Peter Milner
0
Nadia Litterman
0
Mark Midei
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12109194
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0

Find more entities like US Patent 12109194 Synergistic combination therapy for treating ALS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo